CS

Charles L. Sawyers

University of California: 30 patents #83 of 18,278Top 1%
MC Memorial Sloan Kettering Cancer Center: 6 patents #71 of 761Top 10%
SR Sloan Kettering Institute For Cancer Research: 1 patents #325 of 644Top 55%
📍 New York, NY: #323 of 20,192 inventorsTop 2%
🗺 New York: #2,966 of 115,490 inventorsTop 3%
Overall (All Time): #89,655 of 4,157,543Top 3%
37
Patents All Time

Issued Patents All Time

Showing 1–25 of 37 patents

Patent #TitleCo-InventorsDate
11771687 Substituted diazaspiroalkanes as androgen receptor modulators Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2023-10-03
11739069 Modulators of resistant androgen receptor Minna D. Balbas, Michael J. Evans, Yang Shen, David Hosfield, Geoffrey L. Greene 2023-08-29
11446400 Free PSA antibodies as diagnostics, prognostics and therapeutics for prostate cancer David Ulmert, Jason S. Lewis, Michael J. Evans, Hans Lija 2022-09-20
10919929 Glucocorticoid inhibitors for treatment of prostate cancer Vivek Kishorechand Arora, Michael J. Evans, Darren R. Veach 2021-02-16
10857139 Substituted diazaspiroalkanes as androgen receptor modulators Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2020-12-08
10450294 Modulators of resistant androgen receptor Minna D. Balbas, Michael J. Evans, Yang Shen, David Hosfield, Geoffrey L. Greene 2019-10-22
10206911 Androgen receptor variants and methods for making and using Minna D. Balbas, Philip Watson 2019-02-19
9994910 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 Mercedes E. Gorre, Neil Pravin Shah, John Nicoll 2018-06-12
9987261 Substituted diazaspiroalkanes as androgen receptor modulators Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2018-06-05
9650359 Modulators of resistant androgen receptor Minna D. Balbas, Michael J. Evans, Yang Shen, David Hosfield, Geoffrey L. Greene 2017-05-16
9388159 Substituted diazaspiroalkanes as androgen receptor modulators Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2016-07-12
9365542 Modulators of resistant androgen receptor Minna D. Balbas, Michael J. Evans, Yang Shen, David Hosfield, Geoffrey L. Greene 2016-06-14
9261498 Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancer George Thomas 2016-02-16
9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds Michael E. Jung, Charlie D. Chen, Samedy Ouk, Chris Tran, John Wongvipat 2015-09-08
9085644 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 Mercedes E. Gorre, Neil Pravin Shah, John Nicoll 2015-07-21
9056924 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 Mercedes E. Gorre, Neil Pravin Shah, John Nicoll 2015-06-16
8802689 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2014-08-12
8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 Mercedes E. Gorre, Neil Pravin Shah, John Nicoll 2014-04-15
8648105 Diarylthiohydantoin compounds Michael E. Jung, Dongwon Yoo, Chris Tran, John Wongvipat 2014-02-11
8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571 Mercedes E. Gorre, Neil Pravin Shah, John Nicoll 2013-11-19
8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases Michael E. Jung, Samedy Ouk, Chris Tran, John Wongvipat 2013-05-21
8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds Michael E. Jung, Charlie D. Chen, Samedy Ouk, Chris Tran, John Wongvipat 2012-05-22
8110594 Diarylthiohydantoin compounds Michael E. Jung, Dongwon Yoo, Chris Tran, John Wongvipat 2012-02-07
8034548 Methods and materials for assessing prostate cancer therapies Charlie D. Chen, Derek Welsbie 2011-10-11
7718684 Methods and materials for assessing prostate cancer therapies and compounds Michael E. Jung, Samedy Ouk, Charlie D. Chen, Derek Welsbie 2010-05-18